BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35378319)

  • 1. Congenital diaphragmatic hernia and early lethality in PIGL-related disorder.
    Winter-Paquette LM; Al Suwaidi HH; Sajjad Y; Bricker L
    Eur J Med Genet; 2022 May; 65(5):104501. PubMed ID: 35378319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal presentation of Mabry syndrome with congenital diaphragmatic hernia and phenotypic overlap with Fryns syndrome.
    Reynolds KK; Juusola J; Rice GM; Giampietro PF
    Am J Med Genet A; 2017 Oct; 173(10):2776-2781. PubMed ID: 28817240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in PIGL in a patient with Mabry syndrome.
    Fujiwara I; Murakami Y; Niihori T; Kanno J; Hakoda A; Sakamoto O; Okamoto N; Funayama R; Nagashima T; Nakayama K; Kinoshita T; Kure S; Matsubara Y; Aoki Y
    Am J Med Genet A; 2015 Apr; 167A(4):777-85. PubMed ID: 25706356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Child with a mild CHIME syndrome phenotype and carrying a novel p.(Asp52Asn) PIGL pathogenic variant in association with the previously reported p.(Leu167Pro) variant: A case report.
    Rolland M; Dubourg C; Cospain A; Droitcourt C; Pasquier L
    Pediatr Dermatol; 2022 May; 39(3):434-437. PubMed ID: 35258128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphosphatasia with mental retardation syndrome, expanded phenotype of
    Altassan R; Fox S; Poulin C; Buhas D
    Mol Genet Metab Rep; 2018 Jun; 15():46-49. PubMed ID: 30023290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome.
    Ng BG; Hackmann K; Jones MA; Eroshkin AM; He P; Wiliams R; Bhide S; Cantagrel V; Gleeson JG; Paller AS; Schnur RE; Tinschert S; Zunich J; Hegde MR; Freeze HH
    Am J Hum Genet; 2012 Apr; 90(4):685-8. PubMed ID: 22444671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alu-mediated deletion of PIGL in a Patient with CHIME syndrome.
    Knight Johnson A; Schaefer GB; Lee J; Hu Y; Del Gaudio D
    Am J Med Genet A; 2017 May; 173(5):1378-1382. PubMed ID: 28371479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fryns syndrome without diaphragmatic hernia, DOOR syndrome or Fryns-like syndrome? Report on patients from Indian Ocean islands.
    Alessandri JL; Cuillier F; Malan V; Brayer C; Grondard M; Jacquemot-Dekkak L; Kieffer-Traversier M; Pierre F; Laurain C; Samperiz S; Tiran-Rajaofera I; Ramful D
    Am J Med Genet A; 2014 Mar; 164A(3):648-54. PubMed ID: 24357154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Fryns syndrome without diaphragmatic hernia and review of the literature.
    Vasudevan PC; Stewart H
    Clin Dysmorphol; 2004 Jul; 13(3):179-182. PubMed ID: 15194956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroectodermal (CHIME) syndrome: an additional case with long term follow up of all reported cases.
    Shashi V; Zunich J; Kelly TE; Fryburg JS
    J Med Genet; 1995 Jun; 32(6):465-9. PubMed ID: 7666399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fryns syndrome: a rare familial cause of congenital diaphragmatic hernia.
    Langer JC; Winthrop AL; Whelan D
    J Pediatr Surg; 1994 Sep; 29(9):1266-7. PubMed ID: 7807364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Glycosylphosphatidylinositol biosynthesis pathway in human diseases.
    Wu T; Yin F; Guang S; He F; Yang L; Peng J
    Orphanet J Rare Dis; 2020 May; 15(1):129. PubMed ID: 32466763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe congenital ichthyosiform dermatosis in CHIME syndrome successfully treated with ixekizumab.
    Flowers LE; Dyer JA; Eisenstein KA
    Pediatr Dermatol; 2024 May; ():. PubMed ID: 38773877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniorachischisis Totalis with Congenital Diaphragmatic Hernia-A Rare Presentation of Fryns Syndrome.
    Singh A; Pilli GS; Bannur H
    Fetal Pediatr Pathol; 2016; 35(3):192-8. PubMed ID: 27064748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder.
    Thompson MD; Knaus AA; Barshop BA; Caliebe A; Muhle H; Nguyen TTM; Baratang NV; Kinoshita T; Percy ME; Campeau PM; Murakami Y; Cole DE; Krawitz PM; Mabry CC
    Eur J Med Genet; 2020 Apr; 63(4):103822. PubMed ID: 31805394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fryns syndrome without diaphragmatic hernia. Report on a new case and review of the literature.
    Alessandri L; Brayer C; Attali T; Samperiz S; Tiran-Rajaofera I; Ramful D; Pilorget H
    Genet Couns; 2005; 16(4):363-70. PubMed ID: 16440878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGAP3-related hyperphosphatasia with mental retardation syndrome: Report of 10 new patients and a homozygous founder mutation.
    Abdel-Hamid MS; Issa MY; Otaify GA; Abdel-Ghafar SF; Elbendary HM; Zaki MS
    Clin Genet; 2018 Jan; 93(1):84-91. PubMed ID: 28390064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.
    Horn D; Wieczorek D; Metcalfe K; Barić I; Paležac L; Cuk M; Petković Ramadža D; Krüger U; Demuth S; Heinritz W; Linden T; Koenig J; Robinson PN; Krawitz P
    Eur J Hum Genet; 2014 Jun; 22(6):762-7. PubMed ID: 24129430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recessive loss of function PIGN alleles, including an intragenic deletion with founder effect in La Réunion Island, in patients with Fryns syndrome.
    Alessandri JL; Gordon CT; Jacquemont ML; Gruchy N; Ajeawung NF; Benoist G; Oufadem M; Chebil A; Duffourd Y; Dumont C; Gérard M; Kuentz P; Jouan T; Filippini F; Nguyen TTM; Alibeu O; Bole-Feysot C; Nitschké P; Omarjee A; Ramful D; Randrianaivo H; Doray B; Faivre L; Amiel J; Campeau PM; Thevenon J
    Eur J Hum Genet; 2018 Mar; 26(3):340-349. PubMed ID: 29330547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
    Krawitz PM; Murakami Y; Rieß A; Hietala M; Krüger U; Zhu N; Kinoshita T; Mundlos S; Hecht J; Robinson PN; Horn D
    Am J Hum Genet; 2013 Apr; 92(4):584-9. PubMed ID: 23561847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.